A Trusted Data Source for Supply & Demand Side Intelligence

Forgot your login?

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.

E-Mail:
Also, what is 79 + 4?

Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate

Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate

SUGAR LAND--April 30, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Despite a host of headaches, including steep patent losses and an industry in continual reorganization, Pfizer Incorporated (NYSE:PFE) (New York, New York) has managed to remain one of the world's largest drug companies. With revenues of $51.6 billion in 2013, the company is now intent on spending at least $100 billion to snatch up AstraZeneca plc (NYSE:AZN) (London, England).

Other companies featured: Actavis plc (NYSE:ACT), Forest Laboratories Incorporated (NYSE:FRX)

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)